These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2409626)

  • 21. Is protection of ischemic neonatal myocardium by cardioplegia species dependent?
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1990 Feb; 99(2):280-7. PubMed ID: 2299865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ionic bases of cardioplegic solutions. II. Influence of the ionic composition of a cardioplegic solution on the metabolic and functional preservation of ischemic myocardium. Experimental evaluation with phosphorus 31 nuclear magnetic resonance and applications to cardiac surgery].
    Menasche P; Groussett C; Piwnica A
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1465-74. PubMed ID: 6322715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New solution for prolonged myocardial preservation for transplantation.
    Schwalb H; Grinberg L; Yaroslavsky-Houminer E; Lazarovici G; Von Oppell U; Worthington M; Merin G; Borman JB
    J Heart Lung Transplant; 1998 Feb; 17(2):222-9. PubMed ID: 9513861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4 degrees C.
    Choong YS; Gavin JB
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):510-7. PubMed ID: 2308369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of the pediatric myocardium. Differential susceptibility to ischemic injury of the neonatal rat heart.
    Yano Y; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1987 Dec; 94(6):887-96. PubMed ID: 3682858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
    Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
    Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates.
    Bernard M; Menasche P; Canioni P; Fontanarava E; Grousset C; Piwnica A; Cozzone P
    J Thorac Cardiovasc Surg; 1985 Aug; 90(2):235-42. PubMed ID: 2410746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694.
    Myers ML; Karmazyn M
    Ann Thorac Surg; 1996 May; 61(5):1400-6. PubMed ID: 8633949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
    Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Navon G; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of the chronic hypoxic immature rat heart during global ischemia.
    Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
    Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of glucose and oxygen in multidose cold cardioplegia.
    Doherty NE; Turocy JF; Geffin GA; O'Keefe DD; Titus JS; Daggett WM
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):219-29. PubMed ID: 1735987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
    Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
    Kempsford RD; Hearse DJ
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of potassium cardioplegia on high-energy phosphate kinetics during circulatory arrest with deep hypothermia in the newborn piglet heart.
    Clark BJ; Woodford EJ; Malec EJ; Norwood CR; Pigott JD; Norwood WI
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):342-9. PubMed ID: 1992245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution.
    von Oppell UO; Du Toit EF; King LM; Owen P; Dunne T; Reichart B; Opie LH
    J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
    Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long-term hypothermic storage and transplantation.
    Galiñanes M; Hearse DJ
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):151-8. PubMed ID: 1614201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.